News

About Sartorius StedimBiotech Sartorius Stedim Biotech is a leading international partner to the biopharmaceutical industry.
Sartorius Stedim Biotech SA / Key word (s): Expansion Sartorius Stedim Biotech expands manufacturing and R&D capacities for innovative bioprocess solutions in France 17-Jun-2025 / 16:00 CET/CEST ...
Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today celebrates the completion of a multi-year capacity expansion project at its headquarters in Aubagne, France.
The analyst noted that Sartorius Stedim Biotech’s shares have significantly outperformed its peers over the past six months, with a 20% gain compared to the 15-19% decline experienced by competitors ...
About Sartorius Stedim Biotech S.A. Sartorius Stedim Biotech SA provides equipment and services for the development, quality assurance, and production processes of the biopharmaceutical industry.
Sartorius Stedim Biotech reported its first-quarter 2025 results, exceeding company-compiled consensus estimates. Sales and adjusted EBITDA increased in constant currency by 10.4% and 19.9% ...
Investing.com -- Barclays has upgraded Sartorius AG (F: SATG) and its subsidiary Sartorius Stedim (EPA: STDM) Biotech SA (VIE: DIM) to Overweight, citing a shift in the bioprocessing industry ...
A profile of Sartorius Stedim Biotech Sartorius Stedim Biotech is a leading international partner of the biopharmaceutical industry. As a provider of innovative solutions, the company based in Aubagne ...
Sartorius Stedim Biotech S.A. - 13400 Aubagne, France DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Article L 233-8-II of the Code of commerce ...
Shares in Sartorius jumped 15.6% on Tuesday after the Franco-German lab supplies maker's preliminary annual results beat expectations and despite a cautious outlook for 2025.
French biopharmaceutical company Sartorius Stedim Biotech has announced the opening of its new centre for bioprocessing innovation in Marlborough, Massachusetts, US.